Concepedia

Hironobu Hiyoshi

HH

Statistics

Publications

8

Citations

334

H-Index

8

Active since

1994

Affiliations

Eisai (Japan)(Current)

Hironobu Hiyoshi is an author at Eisai (Japan) specializing in pharmacology, molecular pharmacology, and life sciences.

Publications per year

1994–2013

8

Publications

8

In Vitro and In Vivo Activities of E5700 and ER-119884, Two Novel Orally Active Squalene Synthase Inhibitors, against <i>Trypanosoma cruzi</i>

Julio A. Urbina, Juan Luís Concepción, Aura Caldera et al. · Antimicrobial Agents and Chemotherapy · 2004 · 89 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Effect of ER-27856, a novel squalene synthase inhibitor, on plasma cholesterol in rhesus monkeys: comparison with 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors

Hironobu Hiyoshi, Mamoru Yanagimachi, Masashi Ito et al. · Journal of Lipid Research · 2000 · 63 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +15

The novel and orally active thrombin receptor antagonist E5555 (Atopaxar) inhibits arterial thrombosis without affecting bleeding time in guinea pigs

Motoji Kogushi, Toshiyuki Matsuoka, Tsutomu Kawata et al. · European Journal of Pharmacology · 2011 · 48 citations

Medicine, Pharmacology, Clinical Pharmacology +14

Squalene synthase inhibitors suppress triglyceride biosynthesis through the farnesol pathway in rat hepatocytes

Hironobu Hiyoshi, Mamoru Yanagimachi, Masashi Ito et al. · Journal of Lipid Research · 2003 · 46 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Effect of the acyl-CoA:cholesterol acyltransferase inhibitor, E5324, on experimental atherosclerosis in rabbits

Hiroshi Tanaka, Issei Ohtsuka, Motoji Kogushi et al. · Atherosclerosis · 1994 · 33 citations

Life Sciences, Biochemistry, Pharmacology +14

1–5 of 8